10:19am ET
Investing
Own This Cigarette Stock Or Treasuries?
The 5-year U.S. Treasury yield stands at 5.04%. Arguably, U.S. sovereign debt is the safest investment in the world. A bit of doubt has crept in as U.S. debt topped $40 trillion.…
Companies
/Healthcare
Pfizer Inc
$28.69
▲ $0.28 (+0.97%) today
Markets closed · 4:47pm ET
24/7 Wall St. View
Price Prediction
$33.23 +16.9%
Our analysts’ 12-month view: target, optimistic case, and floor.
Full prediction →
Earnings
EPS vs. the estimate, revenue, and how the market reacted.
Total Earnings Coverage →
Fundamentals
Market Cap
$161.9B
P/E Ratio
36.9
Dividend Yield
6.10%
Profit Margin
6.8%
Revenue (TTM)
$63.7B
EPS (TTM)
$0.77
52-Week Range
$22 – $29
Street Target
$28.88
About Pfizer
Pfizer Inc. is a global leader in biopharmaceuticals, offering a wide range of medicines and vaccines. The company focuses on various therapeutic areas including cardiovascular, infectious diseases, women’s health, chronic immune and inflammatory diseases, and more. Pfizer is known for its significant contributions to COVID-19 prevention and treatment with products like Comirnaty and Paxlovid. It also has a strong portfolio in biosimilars and innovative treatments across other serious health conditions. Founded in 1849 and based in New York, Pfizer collaborates with several other healthcare giants to improve global health.
PFE Coverage
1:25pm ET
Investing
These 6 High-Yield Dividends May Be Too Good to Be True
A fat dividend yield can signal a screaming buy or a slow-motion disaster, and the difference hides in coverage math most investors never check. Six well-known names are flashing the exact warning…
11:32am ET
Investing
Eli Lilly Vs. Pfizer in 2027: One Is a Much Better Place to Park Your Pharmaceutical Capital Next Year
Lilly and Pfizer both reported recent quarters that turned heads for opposite reasons, and heading into 2027 only one of them deserves your pharmaceutical capital. The answer depends on a trade-off most…
9:01am ET
Investing
4 Elite Dividend Stocks Yielding Up to 6.14% With Diversified Pipelines That Protect Your Payout
Patent cliffs have buried lesser pharma dividends, yet these four Big Pharma giants keep raising payouts despite losing blockbuster exclusivities worth billions. Find out which one has held its streak for 64…
8:00am ET
Investing
3 Dividend Stocks Trading Cheap Enough to Buy Meaningful Stakes for Under $1,000
AT&T, Verizon, and Pfizer all trade under $50 a share, but a low entry price and genuine value are two very different things, and only one of these three high-yield names carries…
7:34am ET
Investing
Eli Lilly’s Tough Month: One of The Biggest Global Banks Says 37% Gains Begin Soon
Eli Lilly just posted a quarter that crushed estimates on every major metric, yet the stock has spent the past month getting punished anyway. One of Wall Street's biggest banks thinks the…
11:06am ET
Investing
Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing?
Pfizer has raised its dividend every year for over a decade, then something changed. Before you count on that 6% yield, find out what the payout's own behavior is quietly signaling about…
12:17pm ET
Personal Finance
How Much Do You Really Need Invested to Replace a $130,000 Salary With Dividends?
The yield you chase to replace a six-figure salary determines far more than how much capital you need. It quietly sets your exposure to leverage, dividend cuts, and an NAV that can…
9:25am ET
Investing
How a Roth IRA Can Keep Thousands More of Your High-Yield Dividend Income Compounding
Where you hold a high-yield dividend stock matters almost as much as which one you pick, and for ordinary-income payers like BDCs and REITs, the wrong account quietly erodes a portion of…
10:17am ET
Investing
4 High-Yield Dividend Stocks Worth Having in Your Roth IRA
Roth IRAs let dividends compound tax-free forever, which makes them the ideal wrapper for names that spit out ordinary-income distributions taxed at your marginal rate outside the account. The four below yield…
9:19am ET
Investing
Pfizer’s 6% Yield Masks a Fragile Dividend Story
Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the balance sheet leaves almost no room for error. Here is what actually has…
Chris Lange 12:12pm ET
Investing
The Dividend Stocks That Generate $6,400 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)
Holding high-yield dividend stocks like BDCs and REITs in the wrong account silently erases hundreds of dollars every year, and most investors never see it happening until they run the actual numbers.
8:47am ET
Investing
The 10-Year Treasury Pays Nearly 5% These 6 Dividend Stocks Still Pay More
Treasury yields are making income investors work harder than they have in years, and most dividend stocks no longer clear the bar. Six still do, but yield alone is the easy part…
9:04am ET
Personal Finance
How a 74-Year-Old Collects $8,900 a Month Without Selling a Single Share
Collecting $8,900 a month in retirement without selling shares sounds clean until you see what the biggest position in this seven-ticker setup actually pays when markets go quiet.
1:00pm ET
Investing
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now
Pfizer's 5.91% yield draws most of the headlines, but a quietly rerated stock and a pipeline loaded with 2026 catalysts are building a separate case altogether for investors willing to look past…
